AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Eva Ciruelos'
:
Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Publication Year: 2020
DOI: https://doi.org/10.1158/1538-7445.sabcs19-gs3-04
Abstract:
Add to Library
Authors:
Luca Gianni
Chiun‐Sheng Huang
Daniel Egle
Begoña Bermejo
Claudio Zamagni
Marc Thill
Antonio Antón
Stefania Zambelli
Giampaolo Bianchini
Stefania Russo
Eva Ciruelos
R. Greil
Semiglazov Vf
Marco Colleoni
Catherine M. Kelly
Gabriella Mariani
Lucia Del Mastro
I. Maffeis
Pinuccia Valagussa
Giuseppe Viale
Abstract GS3-06: Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Publication Year: 2021
DOI: https://doi.org/10.1158/1538-7445.sabcs20-gs3-06
Abstract:
Add to Library
Authors:
Sara A. Hurvitz
Sara M. Tolaney
Kevin Punie
Thomas Bachelot
Mafalda Oliveira
Kevin Kalinsky
Amelia Zelnak
Philippe Aftimos
Florence Dalenc
Sagar Sardesai
Erika Hamiltion
Helga B. Salvesen
Sabela Recalde
Eva Ciruelos Gil
Tiffany A. Traina
Joyce O’Shaughnessy
Javier Cortés
Michaela L. Tsai
Linda T. Vahdat
Véronique Dièras
Lisa A. Carey
Hope S. Rugo
David M. Goldenberg
Quan Hong
Martin Olivo
Loretta M. Itri
Aditya Bardia
Radiation recall dermatitis induced by pegylated liposomal doxorubicin
Publication Year: 2003
DOI: https://doi.org/10.1097/00001813-200308000-00011
Abstract:
Add to Library
Authors:
Antonio Jimeno
Eva Ciruelos
Daniel Castellano
Begoña Caballero
José Luis Rodríguez‐Peralto
H. Cortés-Funes
Eva Ciruelos: “sin el tabaco evitaríamos uno de cada tres tumores”
Publication Year: 2020
DOI: DOI not
available
Abstract:
Add to Library
Authors:
Abstract CT142: Prevalence of <i>PIK3CA</i>mutations in patients with hormone receptor-positive, human epidermal growth factor-2-negative advanced breast cancer from the SOLAR-1 trial
Publication Year: 2019
DOI: https://doi.org/10.1158/1538-7445.am2019-ct142
Abstract:
Add to Library
Authors:
Hope S. Rugo
Ingrid A. Mayer
Pierfranco Conté
Sibylle Loibl
Mario Campone
Dejan Juric
Fabrice André
Marilyn Fritzemeier
Wei He
Naveen Babbar
Eva Ciruelos
Abstract GS2-07: Results from PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006): A phase 3 trial of Palbociclib (PAL) in combination with endocrine therapy (ET) versus Capecitabine (CAPE) in hormonal receptor (HR)-positive/human epidermal growth factor receptor (HER) 2-negative metastatic breast cancer (MBC) patients (pts) whose disease progressed on aromatase inhibitors (AIs)
Publication Year: 2020
DOI: https://doi.org/10.1158/1538-7445.sabcs19-gs2-07
Abstract:
Add to Library
Authors:
Miguel Martín
Christoph Zielinski
Manuel Ruíz‐Borrego
Eva Carrasco
Eva Ciruelos
Montserrat Muñoz
Begoña Bermejo
Mireia Margelí Vila
Nicholas C. Turner
Maribel Casas
Antonio Antón
Tibor Csöszi
Massimo Corsaro
Laura Murillo
Serafín Morales
Emilio Alba
Cynthia Huang Bartlett
María Koehler
Ángel Guerrero
Zsuzsanna Kahán
Miguel Gil‐Gil
Abstract GS1-11: Sacituzumab Govitecan (SG) vs Treatment of Physician’s Choice (TPC): Efficacy by Trop-2 Expression in the TROPiCS-02 Study of Patients (Pts) With HR+/HER2– Metastatic Breast Cancer (mBC)
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-gs1-11
Abstract:
Add to Library
Authors:
Hope Rugo
Aditya Bardia
Frederik Marmé
Javier Cortés
Peter Schmid
Thomas Bachelot
Olivier Trédan
Eva Ciruelos
Florence Dalenc
P. Gómez Pardo
Komal Jhaveri
Monica Motwani
Oh Kyu Yoon
Hao Wang
Wendy Verret
Sara M. Tolaney
Abstract P3-07-28: SERENA-1: Updated analyses from a Phase 1 study of the next generation oral selective estrogen receptor degrader camizestrant (AZD9833) combined with abemaciclib, in women with ER-positive, HER2-negative advanced breast cancer
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-p3-07-28
Abstract:
Add to Library
Authors:
Nicholas C. Turner
Christos Vaklavas
Emiliano Calvo
Javier García-Corbacho
Jason Incorvati
Manuel Ruíz-Borrego
Chris Twelves
Anne Armstrong
Begoña Bermejo
Erika Hamilton
Mafalda Oliveira
Eva Ciruelos
Peter Kabos
Manish R. Patel
María Borrell
Howard A. Burris
Bruno de Paula
Alejandro Falcón
Cristina Hernándo
Irene Moreno
Ciara O’Brien
Elena Shagisultanova
I. Victoria Ruiz
Judy S. Wang
Mei Wei
Tim Brier
Danielle Carroll
Carmela Ciardullo
Lisa Gibbons
Itziar Irurzun‐Arana
Tony Jack
Bistra Kirova
Teresa Klinowska
Justin P.O. Lindemann
Julie Maidment
Alastair Mathewson
Rhiannon Maudsley
Robert McEwen
Christopher J. Morrow
Andy Sykes
Richard D. Baird
Abstract PD2-07: Alpelisib + letrozole in patients with <i>PIK3CA-</i>mutated, hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) previously treated with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + fulvestrant: BYLieve study results
Publication Year: 2021
DOI: https://doi.org/10.1158/1538-7445.sabcs20-pd2-07
Abstract:
Add to Library
Authors:
Hope S. Rugo
Florence Lerebours
Dejan Juric
Nicholas C. Turner
Stephen Chia
Pamela Drullinsky
Aleix Prat
Rafael Villanueva-Vázquez
Murat Akdere
Christina Arce
Yu-Ming Shen
Eva Ciruelos
Abstract PD8-02: Metformin (MET) for the prevention of Alpelisib (ALP)-related Hyperglycemia (HG) in PIK3CA-mutated, Hormone Receptor-Positive (HR[+]) HER2-Negative (HER2[-]) Advanced Breast Cancer (ABC): The METALLICA study
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-pd8-02
Abstract:
Add to Library
Authors:
Manuel Ruíz-Borrego
Pablo Tolosa
Salvador Blanch
Adela Muñoz Fernández
Ander Urriticoechea
Isabel Blancas
Cristina Saura
Beatriz Rojas
Begoña Bermejo
José Ponce
María Gión
Elisenda Llabrés
Elena Gálve
Juan Cueva
Ana López
José Luis Alonso-Romero
Santiago González-Santiago
Eduardo Martínez de Dueñas
Fernando Gómez-Peralta
Eva Ciruelos
José Manuel Pérez-García
Antonio Llombart‐Cussac
Javier Cortés
Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
Publication Year: 2016
DOI: https://doi.org/10.1200/jco.2015.61.2259
Abstract:
Add to Library
Authors:
Meritxell Bellet
Kathryn P. Gray
Prudence A. Francis
István Láng
Eva Ciruelos
Aña Lluch
Miguel Ángel Climent
Gustavo Catalán
Antoni Avellà
Uriel Bohn
Antonio González-Martı́n
Roser Ferrer
Rosa Catalán
Analía Azaro
Agnita Rajasekaran
Josefa Morales
Josep Vázquez
Gini F. Fleming
Karen N. Price
Meredith M. Regan
Abstract OT2-02-06: Palbociclib in combination with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer with PAM50 luminal intrinsic subtype (SOLTI-1303 PATRICIA II): A multi-center, randomized, open-label, phase II trial
Publication Year: 2020
DOI: https://doi.org/10.1158/1538-7445.sabcs19-ot2-02-06
Abstract:
Add to Library
Authors:
Eva Ciruelos
Patricia Villagrasa
Mafalda Oliveira
Sònia Pernas
Javier Cortés
Silvia Vázquez
Noelia Martínez-Jáñez
Antonia Perelló
Begoña Bermejo
Eduardo Martínez de Dueñas
Isabel Garau
Mireia Melé
Álvaro Montaño
Estela Vega
Blanca Cantos
María J. Echarri
Tomás Pascual
Jordi Canes
P. Céliz
Xavier González
Aleix Prat
Abstract OT-13-04: Solti-1716. Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer patients who have progressed on or after CDK 4/6 inhibitor treatment (TATEN trial)
Publication Year: 2021
DOI: https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04
Abstract:
Add to Library
Authors:
Eva Ciruelos
Tomás Pascual
Núria Chic
Montserrat Muñoz
Begoña Bermejo
Juan Antonio Virizuela
Mafalda Oliveira
Silvia Vázquez
Salvador Blanch
Laia Paré
Fernando Salvador
Patricia Villagrasa
Aleix Prat
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO
Publication Year: 2011
DOI: https://doi.org/10.1016/j.ejca.2011.06.018
Abstract:
Add to Library
Authors:
Xavier Pivot
Andreas Schneeweiß
Shailendra Verma
Christoph Thomssen
José Luís Passos‐Coelho
Giovanni Benedetti
Eva Ciruelos
Roger von Moos
Hong‐Tai Chang
Anja-Alexandra Duenne
David W. Miles
Abstract P3-06-08: Plasma (p) biomarker results from the TANIA trial evaluating continued or reintroduced bevacizumab (BEV) after 1st-line BEV for HER2-negative metastatic breast cancer (mBC)
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.sabcs14-p3-06-08
Abstract:
Add to Library
Authors:
Javier Cortés
Eduard Vrdoljak
Fabio Puglisi
Norbert Marschner
Joseph Gligorov
Christoph Zielinski
Cristian Villanueva
Gilles Romieu
István Láng
Eva Ciruelos
Corinne Veyret
Andrea Fontana
Mikkel Z. Oestergaard
Sabine de Ducla
Ulrich Freudensprung
Gϋnter von Minckwitz
Found 165 results in 0.08 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"